Lekarze w zakresie Terapia celowana za granicą — Strona 3

Dr Erdogan, specjalizujący się w zaawansowanych procedurach endoskopowych, wnosi swoje doświadczenie w zakresie ECPW (ERCP), EUS i leczenia IBD (nieswoistych zapaleń jelit) w szpitalu İstinye University Liv Hospital Topkapı.

• Odbył staż kliniczny (fellowship) w dziedzinie gastroenterologii w Szpitalu Miejskim w Ankarze
• Opublikował liczne artykuły badawcze dotyczące leczenia nieswoistych zapaleń jelit
• Doświadczony w przezustnej miotomii endoskopowej (POEM) i endoskopowej dyssekcji podśluzówkowej (ESD)
• Aktywny autor artykułów w recenzowanych czasopismach naukowych z dziedziny gastroenterologii

Dr. Emad Shash is a medical oncologist who has participated in over 70 oncology clinical trials. He serves as the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. Dr. Shash specializes in systemic therapies, including chemotherapy, targeted therapy, and immunotherapy. He holds a Diploma in Hospital Quality Management and Patient Safety from JCI.

• Serves as an ESMO panel voting member and an ASCO committee member.
• Treats breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers.
• Former research physician and medical lead at the EORTC in Brussels.
• Works at Shefaa Al Orman, an ESMO-accredited oncology center treating 6,000 patients annually.

Dr. Lucía González Cortijo is the Head of Medical Oncology at Hospital Universitario Quirónsalud Madrid. She specializes in breast and gynecologic cancers, including ovarian and cervical malignancies. Dr. González Cortijo holds a PhD cum laude and a Master’s in Molecular Oncology. She focuses on precision oncology, immunotherapy, and targeted treatments.

• Principal Investigator in over 20 Phase II–III clinical trials.
• Participated as a sub-investigator in more than 50 international trials.
• Member of the American Society of Clinical Oncology (ASCO) and ESMO.
• Founder of the La Vida en Rosa Foundation for women with cancer.

Dr. Beni Boursi is a leading oncologist at Sheba Medical Center. He founded the ECOG-ACRIN Microbiome Working Group. He specializes in treating gastrointestinal cancers using innovative microbial modulation. Dr. Boursi is board certified in internal medicine and medical oncology. He earned his medical degree with highest honors from Tel Aviv University.

• Completed oncology fellowships at the University of Pennsylvania.
• Trained in medical oncology at MD Anderson and Mayo Clinic.
• Developed predictive models for early colorectal and pancreatic cancer diagnosis.
• Published research on microbiome-oncology in the prestigious journal Science.

Dr. Nir Kleinmann directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is a pioneer in kidney-sparing laser surgery for complex tumors. Forbes and ResultMed named him among Israel’s Best Doctors for 2025 and 2026. Dr. Kleinmann uses a unique dual-laser system to preserve organ function during cancer treatment.

• Completed urological fellowships at Thomas Jefferson University and McMaster University.
• Expert in minimally invasive treatments for UTUC, kidney stones, and prostate cancer.
• Served as a researcher in the OLYMPUS trial for non-surgical chemoablation.
• Fellow of the American Endourology Society with over 60 scientific publications.

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Dr. Eytan Aharon Ben-Ami leads the Oncology Division at Sheba Medical Center in Israel. He specialized in sarcoma and bone oncology at the Dana-Farber Cancer Institute. Dr. Ben-Ami founded the Sheba Clinical Research Organization to advance cancer studies. He treats rare bone tumors and soft tissue sarcomas with personalized protocols.

• Heads the Early-Phase Clinical Trials Unit for innovative cancer therapies.
• Authored over 40 scientific publications on molecular mechanisms and early detection.
• Leads Phase I trials in targeted therapy and immunotherapy for rare cancers.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He specializes in precision radiation therapy and neuro-oncology. Dr. Lawrence pioneered celiac plexus radiosurgery for pancreatic cancer pain management. He holds the FASTRO designation, one of the highest honors in his specialty.

• Leads the Gastrointestinal Cancer Program at Sheba Medical Center.
• Performs stereotactic radiosurgery for brain tumors and nervous system cancers.
• Authored over 280 scientific publications on personalized radiation protocols.
• Completed radiation oncology fellowship training at Thomas Jefferson University.

Uzm. Dr. Erkan Göcen is a Radiation Oncology Specialist at Çerkezköy Private Optimed Hospital (Optimed Health Group). He graduated from İstanbul University, İstanbul Faculty of Medicine (Çapa) in 2003.

Career: He trained and practiced in Radiation Oncology from 2010 to 2012. He worked in public and private health institutions from 2012 to 2016. He served in the private medical sector as a Radiation Oncology Specialist from 2016 to 2023. He has been at Optimed Hospital since 2024.

Clinical interests: cancers of the brain, head and neck, esophagus, stomach, colorectal, pancreas, prostate, bladder, lung, soft tissues (sarcomas), skin, uterus and cervix, and breast. Affiliations: Turkish Society for Radiation Oncology (TROD) and Tekirdağ Medical Chamber. Languages: English and Turkish.

Dr. Raanan Berger is the Director of the Cancer Center at Sheba Medical Center. He was listed in Forbes Israel’s “Best Doctors” in 2025. Dr. Berger specializes in genitourinary oncology and radiates complex prostate tumors. He completed a postdoctoral fellowship at the Dana-Farber/Harvard Cancer Institute.

• Heads the clinical research unit focusing on molecular oncology.
• Co-authored over 20 peer-reviewed papers on prostate cancer and BRCA mutations.
• Member of the American Society of Clinical Oncology (ASCO).
• Performs systemic therapy and radiotherapy at a Top-10 globally ranked hospital.

Dyrektor kliniczny Interdyscyplinarnego Centrum Leczenia Piersi w Kliniken Essen-Mitte – Sherko Kuemmel kieruje zaawansowanymi badaniami i leczeniem raka piersi.

• 322 recenzowane publikacje na temat raka piersi
• Członek Zarządu AGO – współtworzy wytyczne dotyczące leczenia raka piersi
• Prowadzi międzynarodowe badania kliniczne jako Global PI
• Członek wydziału ESMO w zakresie edukacji o raku piersi

Ordynator Centrum Onkologii w Centrum Medycznym Assuta – wiodący ekspert w terapii celowanej.

• Specjalizuje się w precyzyjnych terapiach onkologicznych
• Bogate doświadczenie w spersonalizowanych terapiach przeciwnowotworowych
• Pracuje w jednym z najlepszych ośrodków onkologicznych w Izraelu

Prof. Elke Jaeger jest czołową specjalistką w dziedzinie mięsaków i jedną z najlepszych onkolożek w Niemczech według rankingu Focus.

• Ponad 35 lat praktyki w onkologii i hematologii
• Kierownik Kliniki Onkologii i Hematologii w Nordwest Clinic
• Specjalizuje się w terapii celowanej w złożonych przypadkach

Dr Eckhart Weidemann kieruje Sektorem Hematologii w Klinice Nordwest — jest specjalistą w zakresie leczenia chorób krwi z ponad 30-letnim doświadczeniem.

• Specjalizuje się w przypadkach chłoniaka nieziarniczego (chłoniaka nie-Hodgkina)
• Kieruje hematologią w Klinice Nordwest
• Profesor z bogatym doświadczeniem akademickim

Prof. Dr. Abdullah Sakin is a Professor of Medical Oncology specializing in the diagnosis and treatment of solid tumors, including lung, breast, gastrointestinal, genitourinary, gynecological, and head and neck cancers, as well as malignant melanoma. He provides personalized cancer care using advanced treatment approaches such as chemotherapy, targeted therapies, immunotherapy, hormone therapy, and precision oncology. With more than 200 scientific publications and active involvement in international clinical research, he is committed to delivering evidence-based, patient-centered cancer care. 


 

Dr Borde przeprowadził ponad 30 000 skanów PET i leczył 1 000 pacjentów z rakiem tarczycy w HCG Manavata Cancer Centre.

• 12 lat doświadczenia w medycynie nuklearnej
• Specjalizuje się w terapiach radiojodem i Lu-177 RN
• Biegły we wszystkich typach skanów nuklearnych i PET-CT
• Opublikowane badania w czasopismach medycznych

35 lat specjalizacji w zakresie ciąż wysokiego ryzyka – dr Vatsa zajmuje się złożonymi przypadkami w Fortis Memorial Research Institute.

• Ekspert w dziedzinie operacji endoskopowych i metod diagnostycznych
• Specjalizuje się w leczeniu ciąży pozamacicznej i poronień
• Autor licznych artykułów z zakresu onkologii ginekologicznej
• Członek Indyjskiego Stowarzyszenia Ginekologów